JPMorgan Chase & Co. Lowers Adient (NYSE:ADNT) Price Target to $37.00

Adient (NYSE:ADNTFree Report) had its price target trimmed by JPMorgan Chase & Co. from $40.00 to $37.00 in a report published on Monday, Benzinga reports. The brokerage currently has a neutral rating on the stock.

A number of other research analysts have also recently weighed in on the stock. Bank of America cut their price objective on shares of Adient from $50.00 to $46.00 and set a buy rating on the stock in a research report on Wednesday, April 10th. Barclays reiterated an equal weight rating and set a $37.00 price objective (down previously from $41.00) on shares of Adient in a research report on Wednesday, April 10th. Finally, Wells Fargo & Company cut their price objective on shares of Adient from $41.00 to $40.00 and set an overweight rating on the stock in a research report on Thursday, February 8th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of Hold and a consensus price target of $42.43.

Get Our Latest Stock Analysis on ADNT

Adient Price Performance

Adient stock opened at $28.99 on Monday. The company has a market cap of $2.65 billion, a price-to-earnings ratio of 12.94, a PEG ratio of 0.30 and a beta of 2.51. The firm’s fifty day moving average is $32.77 and its 200 day moving average is $33.74. The company has a quick ratio of 0.91, a current ratio of 1.15 and a debt-to-equity ratio of 0.92. Adient has a 52-week low of $27.73 and a 52-week high of $46.51.

Adient (NYSE:ADNTGet Free Report) last released its quarterly earnings results on Wednesday, February 7th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.16). The business had revenue of $3.70 billion for the quarter, compared to analysts’ expectations of $3.76 billion. Adient had a net margin of 1.39% and a return on equity of 7.90%. Adient’s revenue for the quarter was up .0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.34 EPS. Sell-side analysts forecast that Adient will post 2.57 EPS for the current fiscal year.

Insider Transactions at Adient

In other news, EVP Heather M. Tiltmann sold 10,000 shares of the company’s stock in a transaction dated Wednesday, February 14th. The shares were sold at an average price of $33.68, for a total value of $336,800.00. Following the transaction, the executive vice president now directly owns 55,669 shares in the company, valued at $1,874,931.92. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ADNT. Headlands Technologies LLC bought a new position in Adient during the 3rd quarter worth about $46,000. Partnership Wealth Management LLC purchased a new stake in shares of Adient during the fourth quarter valued at about $83,000. AM Squared Ltd purchased a new stake in shares of Adient during the third quarter valued at about $106,000. Dark Forest Capital Management LP purchased a new stake in shares of Adient during the third quarter valued at about $205,000. Finally, Handelsinvest Investeringsforvaltning purchased a new stake in shares of Adient during the fourth quarter valued at about $207,000. 92.44% of the stock is currently owned by institutional investors.

About Adient

(Get Free Report)

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.

See Also

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.